Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Extraction of a Stromal Metastatic Gene Signature in Breast Cancer via Spatial Profiling

ABSTRACT: Extraction of a Stromal Metastatic Gene Signature in Breast Cancer via Spatial Profiling

PROVIDER: PRJNA1141928 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30040523_1.fastq.gz	Fastqsanger.gz
	SRR30040523_2.fastq.gz	Fastqsanger.gz
	SRR30040524_1.fastq.gz	Fastqsanger.gz
	SRR30040524_2.fastq.gz	Fastqsanger.gz
	SRR30040525_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Extraction of a Stromal Metastatic Gene Signature in Breast Cancer via Spatial Profiling

Project description:The identification of molecular characteristics that define metastatic disease is a primary research focus across numerous types of malignancies. Understanding the mechanisms that drive metastatic foci, which diverge significantly from the biology of primary tumors, and identifying new biomarkers specifically associated with metastatic disease, is of critical importance in oncology. Consequently, the characterization of the stroma associated with metastatic foci has been largely unexplored and remains an area requiring significant investigation. We identified a detailed transcriptional profile of the stromal compartment within primary tumors and corresponding metastatic foci using spatially resolved approaches. The identified stromal Met signature may serve as a prognostic biomarker and provide insights into the molecular mechanisms underlying the metastatic potential of the tumor microenvironment.

2024-08-04 | GSE273439 | GEO

Stromal gene signature

Project description:Stromal gene signature predictive for PCa metastasis

| PRJEB19256 | ENA

S100A4+ Stromal Cells from Normal Lung vs. Metastatic Lung

Project description:Analysis of S100A4+ stromal cells at the gene expression level in physiological setting versus metastatic setting. Total RNA was isolated from FACS-sorted S100A4+ stromal cells from normal lung of S100A4-GFP transgenic mice compared to FACS-sorted S100A4+ stromal cells from metastatic lung of 4T1 tumor-bearing S100A4-GFP transgenic mice.

2011-08-29 | E-GEOD-31711 | biostudies-arrayexpress

Nicotinamide N-methyltransferase promotes metastatic colonisation via cancer cell stromal mimicry

Project description:Nicotinamide N-methyltransferase promotes metastatic colonisation via cancer cell stromal mimicry.

2023-04-24 | PXD027964 | Pride

Deciphering stromal changes between metastatic and non-metastatic canine mammary carcinomas

Project description:Deciphering stromal changes between metastatic and non-metastatic canine mammary carcinomas

| PRJEB57447 | ENA

S100A4+ Stromal Cells from Normal Lung vs. Metastatic Lung

Project description:Analysis of S100A4+ stromal cells at the gene expression level in physiological setting versus metastatic setting.

2011-08-30 | GSE31711 | GEO

Spatial Transcriptomic Analysis Of Primary And Metastatic Pancreatic Cancers Highlights Tumor Microenvironmental Heterogeneity

Project description:Although the spatial, cellular, and molecular landscapes of resected pancreatic ductal adenocarcinoma (PDAC) are well documented, the characteristics of its metastatic ecology remain elusive. By applying spatially resolved transcriptomics to matched primary and metastatic PDAC samples, we discovered a conserved continuum of fibrotic, metabolic, and immunosuppressive spatial ecotypes across anatomical regions. We observed spatial tumor microenvironment heterogeneity spanning beyond previously appreciated in PDAC. Through comparative analysis, we show the spatial ecotypes exhibit distinct enrichment between primary and metastatic sites, implying adaptability to the local environment for survival and progression. The invasive border ecotype exhibits both protumorigenic and antitumorigenic cell-type enrichment, suggesting a potential immunotherapy target. The ecotype heterogeneity across patients emphasizes the rationale to map individual patient landscapes to develop personalized treatment strategies. Collectively, our findings provide critical insights into metastatic PDAC biology and serve a valuable resource for future therapeutic exploration and molecular investigations.

2024-07-31 | GSE272362 | GEO

Signature of CD45- metastatic niche cells at different stages of the metastatic disease

Project description:Signature of CD45- metastatic niche cells at different stages of the metastatic disease

| PRJNA483753 | ENA

p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy

Project description:p38MAPKa stromal reprogramming sensitizes metastatic breast cancer to immunotherapy

| PRJNA865030 | ENA

Signature of CD45- metastatic niche cells at different stages of the metastatic disease

Project description:We analysed the signature of the non-immune cells from the metastatic niche and the distal lung using the breast tumour 4T1 cell line as a model of lung metastasis from breast cancer

2019-08-28 | GSE117930 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data